Foam cell formation inhibits growth of Chlamydia pneumoniae but does not attenuate Chlamydia pneumoniae-induced secretion of proinflammatory cytokines

Circulation

Volumn 105, Issue 16, 2002, Pages 1976-1982

  Blessing, Erwin ^a   Kuo, Cho Chou ^a   Lin, Tsun Mei ^a   Campbell, Lee Ann ^a   Bea, Florian ^a   Chesebro, Brian ^a   Rosenfeld, Michael E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Atherosclerosis; Infection; Inflammation; Leukocytes; Lipids

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; CELL GROWTH; CHLAMYDOPHILA PNEUMONIAE; CYTOKINE RELEASE; FOAM CELL; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; INFECTION; INFLAMMATION; MACROPHAGE ACTIVATION; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER;

ANIMALS; ARTERIOSCLEROSIS; CELL DIVISION; CELL LINE; CELLS, CULTURED; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL; CYTOKINES; FOAM CELLS; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MICE, INBRED C57BL; NF-KAPPA B; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037161370     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000015062.41860.5B     Document Type: Article

References (24)

1. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
2. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques
3. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain
4. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries
5. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
6. The atherogenic effects of Chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae
7. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice
8. Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice
9. Induction of macrophage foam cell formation by Chlamydia pneumoniae
10. Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells
11. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line
12. A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR
13. Outer membrane complex proteins of Chlamydia pneumoniae
14. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells
15. A rapid microscale procedure for the simultaneous preparation of cytoplasmatic RNA, nuclear DNA binding proteins and enzymatically active luciferase extracts
16. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae
17. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells
18. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse
19. In vitro infection of smooth muscle cells by Chlamydia pneumoniae
20. Analysis of macrophage scavenger receptor (SR-A) expression in human aortic atherosclerotic lesions
21. Cultivation of Chlamydia trachomatis in cycloheximide-treated mccoy cells
22. Expression of the adhesion molecules ICAM, VCAM, and ELAM in the arteriosclerotic plaque
23. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation
24. Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-κB to DNA and the subsequent expression of tumor necrosis factor-α and interleukin-β in macrophages